Powered by

-Innovus Pharmaceuticals Acquires Worldwide Rights to Four Products from Boston Topicals, LLC

Nov 20, 2018 - ENP Newswire

Innovus Pharmaceuticals, Inc., ('Innovus Pharma') (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter and consumer care products to improve men's and women's health and respiratory diseases, announced today that the Company has acquired four branded topical products from Boston Topicals, LLC ('Boston Topicals'), expanding its retail and e-commerce presence in the Company's current highest revenue grossing category.

The products include the diabetic retail category flagship HealthiFeet, a foot cream, with a published double-blind controlled trial shown to increase temperature and blood flow in feet of diabetic patients and formulated with the KNOSIS transdermal delivery system. Innovus Pharma currently plans to launch the products in its sales and marketing platforms in either the fourth quarter 2018 or the first quarter 201...